Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
TRLV · against 1,216 other Healthcare companies
Ranked #956 of 1,217 · scores higher than 21% of peers
Bars: peers in each 10-point band of the growth score121 peers with a growth score of 20–29, including TRLV · Click a bar to see the companies
Mainly because of its earnings per share growth, revenue growth and 3-year revenue growth, which are weaker than most Healthcare peers.
| Metric | TRLV | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | -3.9% | 6.1% | 23% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | -0.6% | 5.8% | 28% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 956 | 17M USD | 21 | 18 | |
| 956 | 9.3B AUD (≈$6.1B) | 21 | 55 | |
| 956 | 31.0B THB (≈$867M) | 21 | 67 | |
| 956 | 304M EUR (≈$334M) | 21 | 42 | |
| 956 | 2.2B USD | 21 | 23 | |
| 968 | 32.3B CNY (≈$4.5B) | 20 | 55 | |
| 968 | 3.4B CNY (≈$472M) | 20 | 56 | |
| 968 | 12.3B TWD (≈$381M) | 20 | 67 | |
| 968 | 9.6B CNY (≈$1.3B) | 20 | 27 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score